Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gufic Biosciences has informed that it enclosed the proceedings of the 38th Annual General Meeting of the Equity Shareholders of the Company held on Friday, September 2, 2022, through Video Conferencing/ Other Audio-Visual Means.
The above information is a part of company’s filings submitted to BSE.